TRIM33 and dermatomyositis: In order to identify disease‐specific gene signatures in DM subgroups, we performed NanoString gene expression analysis with RNA isolated from muscle biopsies obtained from patients with anti‐TIF‐1γ+ and anti‐Mi‐2+ antibodies as well as non‐diseased controls (NDCs).